Preparation and characterization of coacervate microcapsules for the delivery of antimicrobial oyster peptides

Drug Development and Industrial Pharmacy

Volumn 35, Issue 3, 2009, Pages 369-378

  Zhang, Li ^a   Liu, Yezhou ^b   Wu, Zhongchen ^a   Chen, Haixu ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Alginate chitosan starch; Intestinal targeting; Microcapsule; Oyster peptides; pH responsive

Indexed keywords

ALGINIC ACID; CHITOSAN; PEPTIDE DERIVATIVE; STARCH;

ARTICLE; COACERVATION; DRUG CAPSULE; DRUG DELIVERY SYSTEM; INFRARED SPECTROSCOPY; MICROCAPSULE; NONHUMAN; OYSTER; PEPTIDE ANALYSIS; SIMULATION; STOMACH JUICE; SUSTAINED DRUG RELEASE;

ALGINATES; ANIMALS; ANTI-INFECTIVE AGENTS; CAPSULES; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GLUCURONIC ACID; HEXURONIC ACIDS; HYDROGEN-ION CONCENTRATION; INTESTINAL SECRETIONS; OSTREIDAE; PEPTIDES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STARCH; TIME FACTORS;

EID: 61749104106     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802369255     Document Type: Article

References (23)

1. Acosta, N., Aranaz, I., Peniche, C., & Heras, A. (2003). Tramadol release from a delivery system based on alginate-chitosan microcapsules. Macromol Biosci., 3, 546-551.
2. Brange, J. (1987). Galenics of insulin: The physico-chemical and pharmaceutical aspects of insulin and insulin preparations, United States Patent 5534488. Berlin: Springer.
3. Cassidy, A., Bingham, S. A., & Cummings, J. H. (1994). Starch intake and colorectal cancer risk: An international comparison. Br. J. Cancer, 69, 937-942.
4. Chen, X. Q., Jin, Y. Y., & Tang, G. (2003). New pharmacology (15th ed. pp. 186-187). Beijing: People Health Publishing House.
5. Daly, M. M., & Knorr, D. (1988). Chitosan-alginate complex coacervate capsules: Effects of calcium chloride, plasticizer, and polyelectrolyte on mechanical stability. Biotechnol. Prog., 4, 76-81.
6. Gåserød, O., Sannes, A., & Skjåk-Bræk, G. (1999). Microcapsules of alginate-chitosan - II. A study of capsule stability and permeability. Biomaterials, 20, 773-783.
7. Gåserød O., Smidsrød, O., & Skjåk- Bræk, G. (1998). Microcapsules of alginate-chitosan - I. A quantitative study of the interaction between alginate and chitosan. Biomaterials, 19, 1815-1825.
8. Gombotz, W. R., & Wee, S. F. (1998). Protein release from alginate matrices. Adv. Drug Deliv. Rev., 31, 267-285.
9. Hari, P. R., Chandy, T., & Sharma, C. P. J. (1996). Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin. J. Microencapsul., 13, 319-329.
10. Kimura, Y., Tsuruta, T., Hayashi, T., Katsoka, K., Ishihara, K., & Kimura, Y. (1993). Biomedical applications of polymeric materials. Boca Raton, FL: CRC Press Inc.
11. Lemoine, D., Wauters, F., Bouchend'homme, S., & Préat, V. (1998). Preparation and characterization of alginate microspheres containing a model antigen. Int. J. Pharm., 176, 9-19.
12. Liu, Z., Zeng, M., Dong, S., Xu, J., & Song, H. (2007). Effects of antifungal peptides from oyster enzymatic hydrolysates for control of grey mold(Botrytis cinerea)on harvested strawberries. Postharvest Biol. Technol., 46(1), 95-98.
13. Mitrevej, A., Sinchaipanid, N., Rungvejhavuttivittaya, Y., & Kositchaiyong, V. (2001). Multiunit controlled-release diclofenac sodium capsules using complex of chitosan with sodium alginate or pectin. Pharm. Dev. Technol., 6, 385-392.
14. Mumper, R. J., Hoffman, A. S., Puolakkainen, P. A., Bouchard, L. S., & Gombotz, W. R. (1994). Calcium-alginate beads for the oral delivery of transforming growth factor β1 (TGF-β1): Stabilization of TGF-β1 by the addition of polyacrilic acid within acid-treated beads. J. Control. Release, 30, 241-251.
15. Muzzarelli, R. A. (1997). Human enzymatic activities related to the therapeutic administration of chitin derivatives. Cell Mol. Life Sci., 53(2), 131-140.
16. Polk, A., Amsden, B., De Yao, K., Peng, T., & Goosen, M. F. A. (1994). Controlled release of albumin from chitosan-alginate microcapsules. J. Pharm. Sci., 83, 178-185.
17. Rajaonarivony, M., Vauthier, C., Gouarraze, G., Puisieux, F., & Couvreur, P. (1993). Development of a new drug carrier made from alginate. J. Pharm. Sci., 82, 912-917.
18. Ribeiro, A. J., Silva, C., Ferreira, D., & Veiga, F. (2005). Chitosan-reinforced alginate microspheres obtained through the emulsification/internal gelation technique. Eur. J. Pharm. Sci., 25, 31-40.
19. Sezer, A. D., & Akbuga, J. (1999a). Release characteristics of chitosan treated alginate beads: II. Sustained release of a low molecular drug from chitosan treated alginate beads. J. Microencapsul., 16, 687-696.
20. Sezer, A. D., & Akbuǧa, J. (1999b). Release characteristics of chitosan treated alginate beads: I. Sustained release of a macromolecular drug from chitosan treated alginate beads. J. Microencapsul., 16, 195-203.
21. Tapia, C., Escobar, Z., Costa, E., Sapag-Hagar, J., Valenzuela, F., Basualto, C., Gai, M. N., & Yazdani-Pedram, M. (2004). Comparative studies on polyelectrolyte complexes and mixtures of chitosan-alginate and chitosan-carrageenan as prolonged diltiazem clorhydrate release systems. Eur. J. Pharm. Biopharm., 57, 65-73.
22. van der Lubben, I. M., Verhoef, J. C., Borchard, G., & Junginger, H. E. (2001). Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur. J. Pharm. Sci., 14, 201-211.
23. Yuqian, H., Xiaomei, F., Zhiqiang, Z., Xin, J., & Huashi, G. (2007). China patent, Application No. 200610043221.